We are live on
!
Find out more
CIM
Contravisory Investment Management Portfolio holdings
AUM
$566M
1-Year Est. Return
42.93%
This Fund
S&P 500
This Quarter
Est. Return
+2.96%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$450M
AUM Growth
–
Cap. Flow
+$452M
Cap. Flow
% of AUM
100.52%
Top 10 Holdings %
Top 10 Hldgs %
30.22%
Holding
133
New
133
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$16.2M |
| 2 |
KSU
Kansas City Southern
KSU
|
+$15.7M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$14.3M |
| 4 |
Moody's
MCO
|
+$13.6M |
| 5 |
Community Health Systems
CYH
|
+$13.6M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.03% |
| 2 | Industrials | 15.7% |
| 3 | Healthcare | 14.53% |
| 4 | Consumer Discretionary | 10.01% |
| 5 | Materials | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCPC
76
Balchem Corp
BCPC
$5.75B
| $132K | 0.03% |
+2,945
| New | +$132K |
|
77
Rogers Corp
ROG
$2.37B
| $131K | 0.03% |
+2,760
| New | +$126K |
|
|
PDLI
78
DELISTED
PDL BioPharma, Inc.
PDLI
| $129K | 0.03% |
+16,750
| New | +$131K |
|
79
Lithia Motors
LAD
$8.27B
| $128K | 0.03% |
+2,409
| New | +$121K |
|
|
CYT
80
DELISTED
CYTEC INDS INC
CYT
| $127K | 0.03% |
+3,460
| New | +$127K |
|
81
Manhattan Associates
MANH
$10.9B
| $125K | 0.03% |
+6,500
| New | +$119K |
|
82
Modine Manufacturing
MOD
$10.6B
| $125K | 0.03% |
+11,510
| New | +$111K |
|
83
J&J Snack Foods
JJSF
$1.68B
| $124K | 0.03% |
+1,598
| New | +$121K |
|
84
Barings BDC
BBDC
$925M
| $120K | 0.03% |
+4,380
| New | +$122K |
|
|
ALOG
85
DELISTED
Analogic Corp
ALOG
| $119K | 0.03% |
+1,640
| New | +$128K |
|
|
EXAR
86
DELISTED
Exar Corporation
EXAR
| $116K | 0.03% |
+10,762
| New | +$118K |
|
|
SAPE
87
DELISTED
SAPIENT CORP
SAPE
| $113K | 0.03% |
+8,690
| New | +$105K |
|
|
PRMW
88
DELISTED
Primo Water Corporation
PRMW
| $110K | 0.02% |
+14,060
| New | +$128K |
|
89
Idacorp
IDA
$8.24B
| $109K | 0.02% |
+2,275
| New | +$109K |
|
90
Chevron
CVX
$368B
| $100K | 0.02% |
+842
| New | +$102K |
|
91
State Street SPDR S&P 500 ETF Trust
SPY
$821B
| $88K | 0.02% |
+550
| New | +$88.6K |
|
92
Invesco Quality Municipal Securities
IQI
$531M
| $30K | 0.01% |
+2,455
| New | +$31.8K |
|
|
EMC
93
DELISTED
EMC CORPORATION
EMC
| $28K | 0.01% |
+1,200
| New | +$28.3K |
|
94
Thermo Fisher Scientific
TMO
$212B
| $24K | 0.01% |
+285
| New | +$23.7K |
|
95
GE Aerospace
GE
$401B
| $23K | 0.01% |
+209
| New | +$23.1K |
|
96
Berkshire Hathaway Class B
BRK.B
$1.12T
| $22K | ﹤0.01% |
+200
| New | +$22K |
|
97
Vanguard Total Bond Market
BND
$158B
| $21K | ﹤0.01% |
+260
| New | +$21.6K |
|
98
Teradata
TDC
$2.52B
| $21K | ﹤0.01% |
+414
| New | +$22.3K |
|
99
Cheesecake Factory
CAKE
$5.22B
| $18K | ﹤0.01% |
+425
| New | +$16.9K |
|
100
Nature's Sunshine
NATR
$351M
| $16K | ﹤0.01% |
+1,000
| New | +$15.4K |
|
Similar funds
SAM
KJWM
PAM
PEP
LC
BRIM
KBG
AHSW
Contravisory Investment Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Contravisory Investment Management, which disclosed 133 positions worth $450M. Its ten largest holdings account for 30% of the portfolio.
Its largest position is Gilead Sciences: 310,026 shares worth $15.9M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, followed by Industrials and Healthcare.
- Contravisory Investment Management's largest Q2 2013 buy was Gilead Sciences: 310,026 shares worth $15.9M.
- Contravisory Investment Management's ten largest holdings make up 30% of its $450M portfolio in Q2 2013.
- Contravisory Investment Management disclosed 133 positions in Q2 2013, its first 13F filing on record.
Based on Contravisory Investment Management's 13F filing for Q2 2013, filed 15 Jul 2013.